Rare Cancer News & Clinical Trials » Trial - Angiosarcoma

Feeds

4318 items (4318 unread) in 87 feeds

Acinar Cell Carcinoma (24 unread)

• Google - Acinar Cell Carcinoma (1 unread)
• PubMed - Acinar Cell Carcinoma (23 unread)
• Trial - Acinar Cell Carcinoma

Acinic Cell Carcinoma (33 unread)

• Google - Acinic Cell Carcinoma (1 unread)
• PubMed - Acinic Cell Carcinoma (27 unread)
• Trial - Acinic Cell Carcinoma (5 unread)

Adenoid Cystic Carcinoma (83 unread)

• Google - Adenoid Cystic Carcinoma (19 unread)
• PubMed - Adenoid Cystic Carcinoma (44 unread)
• Trial - Adenoid Cystic Carcinoma (20 unread)

Adrenal Gland Cancer (305 unread)

• Google - Adrenal Cancer (83 unread)
• Google - Adrenocortical Carcinoma (4 unread)
• PubMed - Adrenal Cancer (101 unread)
• PubMed - Adrenocortical Carcinoma (31 unread)
• Trial - Adrenal Cancer (63 unread)
• Trial - Adrenocortical Carcinoma (23 unread)

Ampulla Of Vater (23 unread)

• Google - Ampullary Cancer (1 unread)
• PubMed - Ampullary Cancer (18 unread)
• Trial - Ampullary Carcinoma (4 unread)

Anal Cancer (212 unread)

• Google - Anal Cancer (79 unread)
• PubMed - Anal Cancer (93 unread)
• Trial - Anal Cancers (40 unread)

Angiosarcoma (79 unread)

• Google - Angiosarcoma (11 unread)
• PubMed - Angiosarcoma (57 unread)
• Trial - Angiosarcoma (11 unread)

Appendix Cancer (66 unread)

• Google - Appendix Cancer (9 unread)
• PubMed - Appendix Cancer (42 unread)
• Trial - Appendix Cancer (15 unread)

Bile Duct Cancer (332 unread)

• Google - Bile Duct Cancer (77 unread)
• Google - Cholangiocarcinoma (22 unread)
• PubMed - Bile Duct Cancer (68 unread)
• PubMed - Cholangiocarcinoma (138 unread)
• Trial - Bile Duct Cancer (4 unread)
• Trial - Cholangiocarcinoma (23 unread)

Brain and CNS (1194 unread)

• Google - Rare Brain Tumor (83 unread)
• Google - Rare CNS Tumor (9 unread)
• HemeOncLinx - Neurologic Oncology (29 unread)
• PubMed - Ganglioglioma (14 unread)
• PubMed - Rare Brain Tumor (113 unread)
• PubMed - Rare CNS Tumor (181 unread)
• Trial - Brain Tumor (456 unread)
• Trial - CNS Tumor (309 unread)
• Trial - Ganglioglioma

Carcinoid (124 unread)

• Google - Carcinoid (34 unread)
• PubMed - Carcinoid (48 unread)
• Trials - Carcinoid (42 unread)

Endocrine/Neuroendocrine (500 unread)

• Endocrine Oncology (34 unread)
• Google - Merkel Cell Cancer (50 unread)
• PubMed - Merkel Cell Cancer (51 unread)
• Trial - Merkel Cell Cancer
• Trial - Neuroendocrine Cancers (365 unread)

Gall Bladder Cancer (89 unread)

• Google - Gall Bladder Cancer (25 unread)
• PubMed - Gall Bladder Cancer (63 unread)
• Trials - Gall Bladder Cancer (1 unread)

General (4 unread)

• HemeOncLinx - Alternative Therapies (4 unread)

Hemangioendothelioma (38 unread)

• Google - Hemangioendothelioma (3 unread)
• PubMed - Hemangioendothelioma (32 unread)
• Trial - Hemangioendothelioma (3 unread)

HemeOnc (78 unread)

• Bone/Cartilage (9 unread)
• HemeOncLinx - Side Effects (8 unread)
• Hepatobiliary/Pancreas (30 unread)
• Pain/Palliative Care (14 unread)
• Pediatric Heme/Oncology (17 unread)

Hepatoblastoma (46 unread)

• Google - Hepatoblastoma (17 unread)
• PubMed - Hepatoblastoma (21 unread)
• Trial - Hepatoblastoma (8 unread)

Pancreas (76 unread)

• Google - Insulinoma (5 unread)
• PubMed - Insulinoma (61 unread)
• Trial - Insulinoma (10 unread)

Phyllodes (21 unread)

• Google - Phyllodes Tumor (9 unread)
• PubMed - Phyllodes Tumor (12 unread)
• Trial - Phyllodes

PMP and Mucinous Tumors (35 unread)

• Google - Pseudomyxoma Peritonei (14 unread)
• PubMed - Pseudomyxoma Peritonei (PMP) (21 unread)
• Trial - Pseudomyxoma Peritonei

Rhabdomyosarcoma (175 unread)

• Google - Rhabdomyosarcoma (41 unread)
• PubMed - Rhabdomyosarcoma (75 unread)
• Trial - Rhabdomyosarcoma (59 unread)

Sarcoma (313 unread)

• Google - Sarcoma (63 unread)
• HemeOncLinx - Sarcoma (13 unread)
• PubMed - Sarcoma
• Trial - Sarcoma (237 unread)

Twitter Pals (468 unread)

• Twitter / Bruce_S (99 unread)
• Twitter / childrenscancer (160 unread)
• Twitter / LiftUpEllie (113 unread)
• Twitter / LivingBeyond (34 unread)
• Twitter / MDAndersonNews (41 unread)
• Twitter / vaginal_cancer (21 unread)

Trial - Angiosarcoma (11 unread)

• 

  Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma

  Posted: August 25th, 2010, 9:00am CDT

  Condition:   Sarcoma
  Interventions:   Drug: doxorubicin hydrochloride;   Drug: trabectedin;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment
  Sponsor:   European Organization for Research and Treatment of Cancer
  Not yet recruiting - verified August 2010
• 

  GDC-0449 and RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma

  Posted: June 29th, 2010, 9:00am CDT

  Conditions:   Adult Malignant Fibrous Histiocytoma of Bone;   Gastrointestinal Stromal Tumor;   Kidney Cancer;   Malignant Conjunctival Neoplasm;   Ovarian Cancer;   Sarcoma;   Small Intestine Cancer
  Interventions:   Drug: Hedgehog antagonist GDC-0449;   Drug: gamma-secretase inhibitor RO4929097
  Sponsors:   Memorial Sloan-Kettering Cancer Center;   National Cancer Institute (NCI)
  Recruiting - verified June 2010
• 

  Paclitaxel + Bevacizumab (Avastin®) for the Treatment of Metastatic or Unresectable Angiosarcoma

  Posted: January 21st, 2010, 9:00am CST

  Conditions:   Hemangiosarcoma;   Soft Tissue Sarcoma
  Intervention:   Drug: Paclitaxel in combination with Bevacizumab
  Sponsors:   Stanford University;   Genentech
  Recruiting - verified July 2010
• 

  Vorinostat and Bortezomib in Treating Patients With Advanced Soft Tissue Sarcoma

  Posted: July 10th, 2009, 9:00am CDT

  Condition:   Sarcoma
  Interventions:   Drug: bortezomib;   Drug: vorinostat
  Sponsors:   Mayo Clinic;   National Cancer Institute (NCI)
  Active, not recruiting - verified June 2010
• 

  Gemcitabine and Docetaxel With Or Without Bevacizumab in Leiomyosarcoma, Malignant Fibrous Histiocytoma and Angiosarcoma

  Posted: April 23rd, 2009, 9:00am CDT

  Conditions:   Sarcoma;   Leiomyosarcoma;   Malignant Fibrous;   Histiocytoma;   Angiosarcoma
  Interventions:   Drug: gemcitabine and docetaxel with bevacizumab;   Drug: gemcitabine and docetaxel with placebo
  Sponsors:   Memorial Sloan-Kettering Cancer Center;   Genentech
  Active, not recruiting - verified August 2010
• 

  BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors

  Posted: September 5th, 2007, 9:00am CDT

  Conditions:   Breast Cancer;   Endometrial Cancer;   Head and Neck Cancer;   Melanoma (Skin);   Ovarian Cancer;   Sarcoma
  Interventions:   Drug: BI 2536;   Other: high performance liquid chromatography;   Other: mass spectrometry;   Other: pharmacological study
  Sponsor:   European Organization for Research and Treatment of Cancer
  Active, not recruiting - verified May 2010
• 

  Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma

  Posted: December 11th, 2006, 9:00am CST

  Conditions:   Ovarian Cancer;   Sarcoma;   Small Intestine Cancer
  Interventions:   Drug: brostallicin;   Drug: doxorubicin hydrochloride
  Sponsor:   European Organization for Research and Treatment of Cancer
  Active, not recruiting - verified July 2010
• 

  Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma

  Posted: June 28th, 2006, 9:00am CDT

  Conditions:   Childhood Malignant Fibrous Histiocytoma of Bone;   Sarcoma
  Interventions:   Drug: doxorubicin hydrochloride;   Drug: ifosfamide;   Other: clinical observation;   Procedure: therapeutic conventional surgery;   Radiation: radiation therapy
  Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
  Recruiting - verified August 2010
• 

  Bevacizumab in Treating Patients With Angiosarcoma

  Posted: February 6th, 2006, 9:00am CST

  Condition:   Sarcoma
  Intervention:   Biological: Bevacizumab
  Sponsors:   Northwestern University;   Genentech
  Active, not recruiting - verified May 2010
• 

  Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

  Posted: June 5th, 2003, 9:00am CDT

  Condition:   Sarcoma
  Interventions:   Biological: pegfilgrastim;   Drug: doxorubicin hydrochloride;   Drug: ifosfamide;   Procedure: multimodality therapy
  Sponsor:   European Organization for Research and Treatment of Cancer
  Active, not recruiting - verified July 2009
• 

  Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

  Posted: July 8th, 2002, 9:00am CDT

  Conditions:   Gastrointestinal Stromal Tumor;   Sarcoma
  Intervention:   Drug: brostallicin
  Sponsor:   European Organization for Research and Treatment of Cancer
  Active, not recruiting - verified August 2002